Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder.
Journal: The pharmacogenomics journal
Published: March 27, 2018
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
Journal: The New England journal of medicine
Published: March 31, 2016
Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.
Journal: Contemporary clinical trials
Published: November 03, 2014
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.
Journal: Substance abuse
Published: January 24, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026